Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as adjunctive therapy for autism spectrum disorder
IRCT20090117001556N156Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Intensity of irritability. Started Feb 2023; status: completed.
02
Drugs
metformin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT20090117001556N156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N156.